Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.

Fiche publication

Date publication

mai 2015


Journal of clinical oncology : official journal of the American Society of Clinical Oncology


Membres identifiés du Cancéropôle Est :

Tous les auteurs :
Kelly JL, Salles G, Goldman B, Fisher RI, Brice P, Press O, Casasnovas O, Maloney DG, Soubeyran P, Rimsza L, Haioun C, Xerri L, LeBlanc M, Tilly H, Friedberg JW


Recent literature reports a potential association between high vitamin D and improved lymphoma prognosis. We evaluated the impact of pretreatment vitamin D on follicular lymphoma (FL) outcome.

Mots clés

Antibodies, Monoclonal, administration & dosage, Antineoplastic Combined Chemotherapy Protocols, adverse effects, Biomarkers, blood, Chromatography, Liquid, Cyclophosphamide, administration & dosage, Disease Progression, Disease-Free Survival, Doxorubicin, administration & dosage, Female, Humans, Kaplan-Meier Estimate, Lymphoma, Follicular, blood, Male, Middle Aged, Prednisone, administration & dosage, Proportional Hazards Models, Prospective Studies, Risk Factors, Rituximab, administration & dosage, Tandem Mass Spectrometry, Time Factors, Treatment Outcome, Vincristine, administration & dosage, Vitamin D, analogs & derivatives, Vitamin D Deficiency, blood


J. Clin. Oncol.. 2015 May 1;33(13):1482-90